Together we will beat cancer

Lymphoma cells

NICE doesn’t recommend ibrutinib drug for those with Waldenstrom’s macroglobulinaemia

Ibrutinib, a drug used to treat Waldenstrom’s macroglobulinaemia, is not being recommended by the National Institute for Health and Care Excellence in England

Read More

Latest episode of our podcast for researchers

Cancer Research Matters provokes conversation around cancer science, how it shapes our understanding of the disease and the challenges we face as we develop therapies.

Read More

‘From virtual reality tumours to cutting-edge treatments’: what to expect from the Cancer Revolution exhibition

This entry is part 3 of 3 in the series Cancer Revolutionaries

A new exhibition shows the strides scientists have made to unravel the complexities of cancer – and explores what the future holds

Read More

New analysis estimates over 21 million UK adults will be obese by 2040

The results of an analysis published by Cancer Research UK today estimate that more than 21 million UK adults will be obese by 2040

Read More

Improving research with registered reports

Find out what a Registered Report is, how you can get involved, and why this relatively small change in the way research is done could have a real impact on reproducibility issues and even patient outcomes.

Read More

Cannabis, cannabinoids and cancer – the evidence so far

The current consensus is that, right now, there isn’t a large enough body of evidence to prove that cannabis (or any of its active compounds or derivatives) can reliably treat any form of cancer but the medical use of cannabis to treat cancer-related chronic pain is approved in the UK.

Read More

Toothbrushes and ctDNA: Exciting early detection concepts from new teams formed at our sandpit workshops

Our latest sandpit results in exciting new research projects taking on the challenge of cancer early detection and diagnosis. 

Read More

More than 65,000 people are left waiting to find out if it’s cancer each month

New calculations from Cancer Research UK estimate that, on average, over 65,000 people in England are left waiting longer than 28 days to find out whether they have cancer each month.

Read More

How do we die of cancer? What we know (and what we don’t)

This entry is part 2 of 3 in the series Cancer Revolutionaries

We’ve sent robots to mars, split the atom and mapped the human genome. Why, then, is there still so much more to understand about a disease that affects one in two of us?

Read More

A call to action: how our Campaigns Ambassadors are shaping the Government’s 10-year Cancer Plan 

To help revolutionise what cancer outcomes will look like in England in 2032, our Campaigns Ambassadors submitted evidence to inform the Government’s upcoming 10-Year Cancer Plan.

Read More